HealthTree Logo
search more_vert
person Sign In / Create Account

Miriam Kim, MD

Hematologist Oncologist, Instructor of Medicine, Division of Oncology, Washington University School of Medicine

location_city Siteman Cancer Center

10 years treating Acute Myeloid Leukemia

Clinical Expertise

Dr. Kim's goal is to develop chimeric antigen receptor T cells as a safe and effective therapy for AML. To this end, I am exploring different target antigens for CAR T cell therapy, investigating mechanisms to enhance the anti-tumor effect of CAR T cells, and finding methods to circumvent the toxicity associated with T cell immunotherapy in the setting of myeloid malignancies.


Siteman Cancer Center: 4921 Parkview Pl, St. Louis, MO 63110, USA

Get the latest thought leadership on Acute Myeloid Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Acute Myeloid Leukemia Newsletter" for Acute Myeloid Leukemia news, life with Acute Myeloid Leukemia stories, Acute Myeloid Leukemia clinical trials, Acute Myeloid Leukemia 101 articles and events with Acute Myeloid Leukemia experts.

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Astellas Pharma

Follow Us

facebook instagram youtube